Broad Sky Partners has acquired Thomas Scientific from The Carlyle Group, according to a news release.

Thomas Scientific, based in Swedesboro, N.J., and founded in 1900, is a provider of supplies to the healthcare, biotech, clinical diagnostics and life sciences industries.

Broad Sky Partners, based in New York City, is a private equity firm that pursues primary control and strategic minority investments in middle market business services and consumer companies. The acquisition of Thomas Scientific is the firm’s first transaction.

Carlyle, with its U.S. headquarters in Washington, D.C., is a global investment firm that deploys private capital across three business segments: global private equity, global credit and investment solutions. Founded in 1987, the firm targets companies in healthcare and many other industries.

Terms of the transaction were not disclosed.